UFP Technologies, Inc. (UFPT)
NASDAQ: UFPT · Real-Time Price · USD
195.42
-3.92 (-1.97%)
At close: Oct 15, 2025, 4:00 PM EDT
196.62
+1.20 (0.61%)
Pre-market: Oct 16, 2025, 5:06 AM EDT
UFP Technologies Market Cap
UFP Technologies has a market cap or net worth of $1.51 billion as of October 16, 2025. Its market cap has decreased by -38.00% in one year.
Market Cap
1.51B
Enterprise Value
1.67B
1-Year Change
-38.00%
Ranking
Category
Stock Price
$195.42
Market Cap Chart
Since December 1, 1998, UFP Technologies's market cap has increased from $15.40M to $1.51B, an increase of 9,685.12%. That is a compound annual growth rate of 18.58%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 15, 2025 | 1.51B | -19.70% |
Dec 31, 2024 | 1.88B | 42.79% |
Dec 29, 2023 | 1.31B | 47.10% |
Dec 30, 2022 | 893.40M | 68.82% |
Dec 31, 2021 | 529.20M | 51.50% |
Dec 31, 2020 | 349.30M | -5.34% |
Dec 31, 2019 | 369.00M | 66.59% |
Dec 31, 2018 | 221.50M | 9.65% |
Dec 29, 2017 | 202.00M | 9.78% |
Dec 30, 2016 | 184.00M | 8.24% |
Dec 31, 2015 | 170.00M | -2.02% |
Dec 31, 2014 | 173.50M | -0.12% |
Dec 31, 2013 | 173.70M | 44.03% |
Dec 31, 2012 | 120.60M | 25.10% |
Dec 30, 2011 | 96.40M | 27.18% |
Dec 31, 2010 | 75.80M | 96.88% |
Dec 31, 2009 | 38.50M | 29.19% |
Dec 31, 2008 | 29.80M | -24.56% |
Dec 31, 2007 | 39.50M | 36.68% |
Dec 29, 2006 | 28.90M | 153.51% |
Dec 30, 2005 | 11.40M | -35.23% |
Dec 31, 2004 | 17.60M | 100.00% |
Dec 31, 2003 | 8.80M | 95.56% |
Dec 31, 2002 | 4.50M | - |
Dec 31, 2001 | 4.50M | -39.19% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 742.04B |
Johnson & Johnson | 460.40B |
AbbVie | 399.63B |
UnitedHealth Group | 327.08B |
AstraZeneca | 262.65B |
Novartis AG | 252.43B |
Novo Nordisk | 251.88B |
Abbott Laboratories | 225.30B |